Development and external validation of a novel online calculator for predicting long-term survival following radical hepatectomy in patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension [0.03%]
Tianyin Shao,Hanlong Hu,Yuanqiu Li et al.
Tianyin Shao et al.
Background: Patients with hepatocellular carcinoma (HCC) and clinically significant portal hypertension (CSPH) experience a poorer prognosis following hepatectomy (Hx). This study aimed to develop a calculator to estimate...
Adding pembrolizumab to standard neoadjuvant chemoradiotherapy is not associated with increased postoperative complications after esophagectomy in ESCC: a retrospective analysis from a prospective database [0.03%]
Lei Yao,Wei-Xiang Qi,Shuyan Li et al.
Lei Yao et al.
Background: The current standard of care for locally advanced esophageal squamous cell carcinoma (ESCC) consists of neoadjuvant chemoradiotherapy (nCRT) followed by curative surgery. Recent single-arm trials have demonstr...
Use of uterine manipulators in endometrial cancer surgery: Balancing benefits and uncertainties [0.03%]
Marco D&#x;Indinosante,Matteo Bruno,Fausto Napolitano et al.
Marco D&#x;Indinosante et al.
Objective: Intrauterine manipulators are commonly used for minimally invasive hysterectomy for endometrial cancer yet concerns regarding tumor spillage and oncologic safety remain debated. This review aims to synthesize c...
Long-term implications of using preoperative oral antibiotics to prevent surgical-site infections in colon surgery: a follow-up study from ORALEV RCT [0.03%]
Gianluca Pellino,María Martínez-López,Eleanor Rudge et al.
Gianluca Pellino et al.
Background: ORALEV-RCT demonstrated that preoperative oral antibiotics (OA) before colon surgery reduces surgical-site infections. There was concern regarding a potential risk of antibiotic resistance. ...
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database [0.03%]
Sophie Le Bars,Catherine Guerin-Charbonnel,Elodie Martin et al.
Sophie Le Bars et al.
Introduction: Benefits on survival of retroperitoneal lymph node (LN) dissection during cytoreductive surgery (CRS) for epithelial ovarian cancer are debated. However, LN involvement may be a prognostic factor especially ...
Women in surgical oncology [0.03%]
Lynda Wyld,Isabel T Rubio
Lynda Wyld
Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis [0.03%]
Kai-Yuan Jiang,Lu-Dan Zhang,Ai-Ling Zhong et al.
Kai-Yuan Jiang et al.
Background: cT4 esophageal cancer represents a major therapeutic challenge, with definitive chemoradiotherapy (dCRT) currently considered the standard treatment. However, survival outcomes remain unsatisfactory. CS follow...
Postoperative complications and prognosis after splenectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [0.03%]
Lana Ghanipour,Mariam Rashed,Mirna Abraham-Nordling et al.
Lana Ghanipour et al.
Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment for peritoneal metastases (PM) of various origins. The spleen is frequently involved in advanced di...
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis [0.03%]
Pietro Bertoglio,Filippo Tommaso Gallina,Eleonora Balzani et al.
Pietro Bertoglio et al.
Introduction: The integration of immune checkpoint inhibitors (ICIs) into the management of resectable non-small cell lung cancer (NSCLC) has markedly improved pathological response and survival. However, the effect of IC...
Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer [0.03%]
Eva L Claassens,Linetta B Koppert,Carmen C van der Pol et al.
Eva L Claassens et al.
Objective: To determine how often the indication for adjuvant systemic therapy (AST) in HER2+ and TN breast cancer is based solely on residual axillary disease (ypT0N+) and to estimate the theoretical frequency with which...